Just spent some time reading previous comments by @otherperspective quite insightful and very well articulated. I'm sure many of us would like to hear from him leading into the imminent FDA decision particularly on whether CHF is gaining traction
- Forums
- ASX - By Stock
- MSB
- Ann: Appendix 3G, Appendix 3H and Appendix 3Ys
Ann: Appendix 3G, Appendix 3H and Appendix 3Ys, page-25
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.51 |
Change
-0.005(0.33%) |
Mkt cap ! $1.701B |
Open | High | Low | Value | Volume |
$1.50 | $1.53 | $1.48 | $2.824M | 1.883M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 22245 | $1.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.51 | 51349 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 23570 | 1.505 |
16 | 85450 | 1.500 |
7 | 26883 | 1.495 |
6 | 45164 | 1.490 |
6 | 109720 | 1.485 |
Price($) | Vol. | No. |
---|---|---|
1.510 | 50696 | 4 |
1.515 | 45966 | 8 |
1.520 | 44815 | 8 |
1.525 | 79642 | 9 |
1.530 | 154745 | 9 |
Last trade - 12.22pm 13/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online